Cocrystal Pharma, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Cocrystal Pharma, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2011 to Q4 2023.
  • Cocrystal Pharma, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $31.5M, a 14.3% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $31.5M +$3.94M +14.3% Dec 31, 2023 10-K 2024-03-28
Q4 2022 $27.5M +$3.94M +16.7% Dec 31, 2022 10-K 2024-03-28
Q4 2021 $23.6M +$3.16M +15.5% Dec 31, 2021 10-K 2023-03-29
Q4 2020 $20.4M +$2.17M +11.9% Dec 31, 2020 10-K 2022-03-23
Q4 2019 $18.3M -$1.5M -7.6% Dec 31, 2019 10-K 2021-03-17
Q4 2018 $19.8M +$1.94M +10.9% Dec 31, 2018 10-K 2020-03-27
Q4 2017 $17.8M -$6.07M -25.4% Dec 31, 2017 10-K 2019-04-01
Q4 2016 $23.9M +$7.45M +45.2% Dec 31, 2016 10-K 2018-03-21
Q4 2015 $16.5M +$8.48M +106% Dec 31, 2015 10-K 2017-03-31
Q4 2014 $7.99M +$14.7M Dec 31, 2014 10-K 2016-03-15
Q4 2013 -$6.68M -$4.49M -205% Dec 31, 2013 10-K 2015-03-31
Q4 2012 -$2.19M -$1.01M -85.2% Dec 31, 2012 10-K 2014-03-31
Q4 2011 -$1.18M Dec 31, 2011 10-K 2013-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.